Tocilizumab Employment in the Treatment of Resistant Juvenile Idiopathic Arthritis Associated Uveitis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tocilizumab Employment in the Treatment of Resistant Juvenile Idiopathic Arthritis Associated Uveitis
Authors
Keywords
-
Journal
OCULAR IMMUNOLOGY AND INFLAMMATION
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2020-10-06
DOI
10.1080/09273948.2020.1817501
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-il6-r tocilizumab in refractory and non-infectious uveitic cystoid macular edema. Multicenter study of 25 patients
- (2019) Nuria Vegas-Revenga et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Juvenile idiopathic arthritis-associated uveitis
- (2019) Ethan S. Sen et al. CLINICAL IMMUNOLOGY
- Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis–associated Uveitis
- (2017) ESTEFANIA QUESADA-MASACHS et al. JOURNAL OF RHEUMATOLOGY
- Trial of Tocilizumab in Giant-Cell Arteritis
- (2017) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients
- (2017) Vanesa Calvo-Río et al. Arthritis & Rheumatology
- Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
- (2016) C. Tappeiner et al. JOURNAL OF RHEUMATOLOGY
- Managing juvenile idiopathic arthritis–associated uveitis
- (2016) Madeleine J. Hawkins et al. SURVEY OF OPHTHALMOLOGY
- Erythrocyte Sedimentation Rate as Baseline Predictor for the Development of Uveitis in Children With Juvenile Idiopathic Arthritis
- (2015) Arenda J.W. Haasnoot et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
- (2014) Hermine I Brunner et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment of juvenile idiopathic arthritis: a revolution in care
- (2014) Matthew L Stoll et al. Pediatric Rheumatology
- A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)
- (2013) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Brief Report: Anti-Tumor Necrosis Factor α Targets Protein Kinase B/c-Akt-Induced Resistance of Effector Cells to Suppression in Juvenile Idiopathic Arthritis
- (2013) Ellen J. Wehrens et al. ARTHRITIS AND RHEUMATISM
- Tocilizumab treatment for refractory uveitis-related cystoid macular edema
- (2013) Alfredo Adán et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- IL-6 polymorphisms: a useful genetic tool for inflammation research?
- (2013) Patricia Woo et al. JOURNAL OF CLINICAL INVESTIGATION
- Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
- (2013) Carmen García-De-Vicuña et al. MEDIATORS OF INFLAMMATION
- Tocilizumab for Severe Chronic Anterior Uveitis Associated with Juvenile Idiopathic Arthritis in a Pediatric Patient
- (2013) Adrian C. Tsang et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Expert Panel Recommendations for the Use of Anti–Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders
- (2013) Grace Levy-Clarke et al. OPHTHALMOLOGY
- Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry
- (2012) M. E. ZANNIN et al. JOURNAL OF RHEUMATOLOGY
- Is Tocilizumab an Effective Option for Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis?
- (2012) C. TAPPEINER et al. JOURNAL OF RHEUMATOLOGY
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started